LABORATORY RESEARCH CD133 Is a Positive Marker for a Distinct Class of Primitive Human Cord Blood-Derived CD34-Negative Hematopoietic Stem Cells Using 18Lin–CD34– cells, scientists analyzed the expression of candidate positive markers by FCM. They finally identified CD133 as a reliable positive marker of human CB-derived CD34– SCID-repopulating cells and succeeded in highly purifying primitive human CD34– hematopoietic stem cells. [Leukemia] Abstract Lamins Regulate Cell Trafficking and Lineage Maturation of Adult Human Hematopoietic Cells Researchers hypothesized that cell sorting across microporous barriers is regulated by nuclear deformability as controlled by lamin-A and -B, and lamin levels directly modulate hematopoietic programs. [Proc Natl Acad Sci USA] Abstract Human ProT-Cells Generated In Vitro Facilitate Hematopoietic Stem Cell-Derived T-Lymphopoiesis In Vivo and Restore Thymic Architecture Researchers addressed whether in vitro-derived human progenitor T-cells (proT) could not only represent a source of thymus-seeding progenitors but also be able to influence the recovery of the thymic microenvironment. [Blood] Abstract The Small Molecule Me6TREN Mobilizes Hematopoietic Stem/Progenitor Cells by Activating MMP-9 Expression and Disrupting SDF-1/CXCR4 Axis Investigators report that the molecule Me6TREN (Me6) can induce rapid mobilization of hematopoietic progenitor cells, and that Me6 exhibits more significant effects than G-CSF or AMD3100. [Blood] Abstract Stress Hematopoiesis Is Regulated by the Krüppel-Like Transcription Factor ZBP-89 Researchers showed that conditional deletion of ZBP-89 in adult mouse hematopoietic stem/progenitor cells causes anemia and thrombocytopenia that are transient in the steady state, but readily uncovered following chemically induced erythro/megakaryopoietic stress. [Stem Cells] Abstract Exonuclease 1 Is a Critical Mediator of Survival during DNA Double Strand Break Repair in Non-Quiescent Hematopoietic Stem and Progenitor Cells Scientists used cultured Exo1mut fibroblasts and bone marrow to demonstrate that loss of Exo1 function results in defective homologous recombination (HR) in cycling cells. Conversely in Exo1mut mice HR is not required for maintenance of quiescent hematopoietic stem cells (HSCs) at steady state, confirming the steady state HSC reliance on non-homologous end joining. [Stem Cells] Abstract Resistance of Hematopoietic Progenitors to Fas-Mediated Apoptosis Is Actively Sustained by NFκB with a Characteristic Transcriptional Signature Researchers evaluated the molecular mechanisms of progenitor resistance to apoptosis triggered by Fas cross-linking. CD34+ and lineage-negative progenitors survive short-term ex vivo incubation and are not induced into apoptosis by Fas cross-linking. [Stem Cells Dev] Abstract Autocrine GM-CSF Transcription in the Leukemic Progenitor Cell Line KG1a Is Mediated by the Transcription Factor ETS1 and Is Negatively Regulated through SECTM1 Mediated Ligation of CD7 Secreted and transmembrane protein 1 (SECTM1) is expressed in Human Bone Marrow Endothelial Cells and its expression can be upregulated by IFN-γ. KG1a cells demonstrated high expression levels of CD7 and ETS-1 allowing a constitutative signaling through the PI3K/Atk pathway to promote GM-CSF expression, while KG1 cells with low expression of CD7 and ETS-1 showed low GM-CSF expression. [Biochim Biophys Acta] Abstract CLINICAL RESEARCH Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphomas: A Study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas Researchers performed a multicenter retrospective analysis of 37 cases of advanced-stage primary cutaneous T-cell lymphomas treated with allogeneic stem cell transplantation, including 20 transformed mycosis fungoides. [Haematologica] Abstract High Incidence of Chronic Graft-Versus-Host Disease after Myeloablative Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in Sweden: Graft-Versus-Leukemia Effect Protects against Relapse Between 1994 and 2007, 48 adults underwent allo-stem cell transplantation for poor-risk chronic lymphocytic leukemia in Sweden. The cumulative incidence of acute graft-versus-host disease grades II-IV was 30%. The probabilities of relapse-free and overall survival from 1, 3 and 5 years after transplantation were 100, 90 and 70%, and 100, 90 and 80%, respectively. [Med Oncol] Abstract |